10/16
08:08 am
clym
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
Low
Report
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock.
10/16
08:08 am
clym
Climb Bio (NASDAQ:CLYM) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Climb Bio (NASDAQ:CLYM) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
10/16
08:08 am
clym
Climb Bio (NASDAQ:CLYM) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
Low
Report
Climb Bio (NASDAQ:CLYM) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
10/16
07:01 am
clym
Rating for CLYM
Medium
Report
Rating for CLYM
10/16
07:01 am
clym
Rating for CLYM
Medium
Report
Rating for CLYM
10/16
06:28 am
clym
Rating for CLYM
Low
Report
Rating for CLYM
10/16
06:14 am
clym
Climb Bio initiated with an Outperform at William Blair
Low
Report
Climb Bio initiated with an Outperform at William Blair
10/16
06:14 am
clym
Climb Bio initiated with an Outperform at William Blair
Low
Report
Climb Bio initiated with an Outperform at William Blair
10/14
07:57 am
clym
Climb Bio (NASDAQ:CLYM) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
Low
Report
Climb Bio (NASDAQ:CLYM) was upgraded by analysts at HC Wainwright to a "strong-buy" rating.
10/13
07:05 am
clym
Climb Bio (NASDAQ:CLYM) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
Medium
Report
Climb Bio (NASDAQ:CLYM) is now covered by analysts at HC Wainwright. They set a "buy" rating on the stock.
10/13
06:12 am
clym
Climb Bio initiated with a Buy at H.C. Wainwright
High
Report
Climb Bio initiated with a Buy at H.C. Wainwright
10/13
06:12 am
clym
Climb Bio initiated with a Buy at H.C. Wainwright
High
Report
Climb Bio initiated with a Buy at H.C. Wainwright
9/30
08:04 am
clym
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock, up previously from $7.00.
Report
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $8.00 price target on the stock, up previously from $7.00.
9/30
07:23 am
clym
Rating for CLYM
Low
Report
Rating for CLYM
9/22
11:02 am
clym
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $7.00 price target on the stock.
Low
Report
Climb Bio (NASDAQ:CLYM) had its "buy" rating reaffirmed by analysts at BTIG Research. They now have a $7.00 price target on the stock.
9/22
10:27 am
clym
Rating for CLYM
Low
Report
Rating for CLYM